The role of basiliximab in the evolving renal transplantation immunosuppression protocol.
Basiliximab is a chimeric mouse-human monoclonal antibody directed against the alpha chain of the interleukin-2 (IL-2) receptor on activated T lymphocytes. It was shown in phase III trials to reduce the number and severity of acute rejection episodes in the first year following renal transplantation in adults and children, with a reasonable cost-benefit ratio. The drug does not increase the incidence of opportunistic infections or malignancies above baseline in patients treated with conventional calcineurin inhibitor-based immunosuppression. In the field of renal transplantation, basiliximab does not increase kidney or patient survival, despite the reduction in the number of rejection episodes. Basiliximab may reduce the incidence of delayed graft function. In comparison with lymphocyte-depleting antibodies basiliximab appears to have equal efficacy in standard immunological risk patients. Recently, IL-2 receptor monoclonal antibodies have been used with the objective of reducing or eliminating the more toxic elements of the standard immunosuppression protocol. Several trials have incorporated basiliximab in protocols designed to avoid or withdraw rapidly corticosteroids, as well as protocols which substitute target-of-rapamycin (TOR) inhibitors for calcineurin inhibitors.
Salis
Paola
P
Division of Nephrology and Division of Abdominal Transplantation, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione, Palermo, Italy.
Caccamo
Chiara
C
Verzaro
Roberto
R
Gruttadauria
Salvatore
S
Artero
Mary
M
Am J Transplant. 2006 Jul;6(7):1666-72
16827869
Clin Transplant. 2003 Aug;17(4):369-76
12868995
Am J Transplant. 2003 Mar;3(3):306-11
12614286
Transplant Proc. 2002 Aug;34(5):1730-2
12176554
BioDrugs. 2003;17(4):271-9
12899644
Clin Transplant. 2005 Dec;19(6):705-10
16313313
Lancet. 2000 Oct 14;356(9238):1327-8
11073027
Transplantation. 2004 Aug 27;78(4):584-90
15446319
Proc Natl Acad Sci U S A. 1989 Dec;86(24):10029-33
2513570
Ann Rheum Dis. 2000 Nov;59 Suppl 1:i109-14
11053100
Transplantation. 2005 Dec 27;80(12):1734-41
16378069
Transplantation. 2005 Feb 15;79(3):344-8
15699766
Drugs Aging. 2004;21(11):747-56
15323580
Transplant Proc. 2001 Nov-Dec;33(7-8):3180-3
11750365
Transplantation. 2004 Sep 27;78(6):904-10
15385812
Transplant Proc. 2001 May;33(3):2380
11377567
Drugs. 2003;63(24):2803-35
14664658
Transplant Proc. 2005 Mar;37(2):903-5
15848570
Transpl Int. 2004 Sep;17(8):395-401
15365604
Transplant Proc. 2001 Nov-Dec;33(7-8):3195-6
11750370
Transplantation. 2004 Jan 27;77(2):166-76
14742976
Nephrol Dial Transplant. 2002 Feb;17(2):276-80
11812879
Pediatr Transplant. 2001 Aug;5(4):297-301
11472610
Expert Opin Biol Ther. 2007 Jan;7(1):137-48
17150025
Nephrol Dial Transplant. 2004 Jun;19 Suppl 3:iii32-7
15192133
Transplantation. 2006 Mar 27;81(6):949-52
16570022
Clin Transplant. 2004 Apr;18(2):113-8
15016122
Transplant Proc. 2003 Jun;35(4):1326-7
12826150
Transplantation. 2001 Oct 15;72(7):1261-7
11602853
Nat Immunol. 2005 Apr;6(4):345-52
15785760
Transplant Proc. 2000 Dec;32(8):2757-9
11134788
Drug Saf. 2004;27(2):91-106
14717621
Pediatr Nephrol. 2001 Sep;16(9):693-6
11511978
Transplantation. 2006 Dec 15;82(11):1533-6
17164728
Pharmacoeconomics. 2003;21(2):129-38
12515574
Transplant Proc. 2005 Mar;37(2):875-8
15848561
Transplantation. 1997 Dec 27;64(12):1701-5
9422405
Clin Transplant. 2005 Feb;19(1):61-9
15659136
Transplantation. 2003 Mar 27;75(6):796-9
12660504
Paediatr Drugs. 2003;5(10):699-716
14510627
Transpl Int. 1996;9 Suppl 1:S32-3
8959785
Transpl Int. 2002 Oct;15(9-10):486-93
12389081
Am J Transplant. 2005 Mar;5(3):454-64
15707399
BMJ. 2003 Apr 12;326(7393):789
12689974
Transplant Proc. 2006 Sep;38(7):2298-9
16980070
Lancet. 1997 Oct 25;350(9086):1193-8
9652559
Am J Transplant. 2006;6(5 Pt 2):1111-31
16613591
Am J Transplant. 2005 Oct;5(10):2531-8
16162204
Clin Transplant. 2001 Apr;15(2):123-30
11264639
Transplantation. 1993 May;55(5):993-5
8497913
Pharmacotherapy. 2003 Apr;23(4):443-50
12680474
Transplantation. 2005 Jul 15;80(1):110-7
16003241
Am J Kidney Dis. 2001 Jan;37(1):E11
11136200
Clin Transplant. 2000 Oct;14(5):479-85
11048993
Nephrol Dial Transplant. 2002 Jul;17(7):1304-9
12105256
J Immunol. 1981 Apr;126(4):1398-403
6451645
Transplantation. 2000 Sep 15;70(5):784-90
11003358
Transplant Proc. 2004 Sep;36(7):2110-2
15518764
Transplant Proc. 2001 Feb-Mar;33(1-2):1057-8
11267189
Transplantation. 2002 Oct 15;74(7):966-71
12394838
Am J Transplant. 2002 Jan;2(1):48-56
12095056
Transplant Proc. 2001 Nov-Dec;33(7-8):3213-4
11750379
Transplantation. 2001 Dec 27;72(12):1915-9
11773888
Am J Transplant. 2005 Jan;5(1):157-66
15636625
Transplant Proc. 2005 Mar;37(2):879-80
15848562
Transplantation. 1999 Nov 15;68(9):1288-94
10573065
QJM. 2003 Feb;96(2):91-102
12589007
J Nephrol. 2003 May-Jun;16(3):393-8
12832740
Transplantation. 2001 May 15;71(9):1320-8
11397971
Transplantation. 1999 Jan 27;67(2):276-84
10075594
Transplantation. 2004 May 27;77(10):1545-50
15239619
Transplantation. 2003 Aug 15;76(3):459-63
12923429
Transplantation. 2003 Jan 15;75(1):37-43
12544868
Transplantation. 1997 May 15;63(9):1268-72
9158020
Pediatr Transplant. 2005 Feb;9(1):80-3
15667617
Transplantation. 2005 Mar 27;79(6):716-21
15785379
Nephrol Dial Transplant. 2001 Sep;16(9):1756-60
11522853
Am J Nephrol. 2005 May-Jun;25(3):221-5
15908741
Transplantation. 2004 May 15;77(9):1477-8
15167617
Am J Transplant. 2005 Oct;5(10):2539-48
16162205
N Engl J Med. 2006 Nov 9;355(19):1967-77
17093248
Kidney Int. 2005 Apr;67(4):1622-9
15780120
Transplantation. 1995 Oct 15;60(7):748-56
7570988